MOdel-informed precision dosing (MIPD) of ustekinumab and VEdolizumab in inflammatory bowel disease: protocol for an Independent randomised, controlled, multicentre Trial (MOVE-IT).

Saved in:
Bibliographic Details
Title: MOdel-informed precision dosing (MIPD) of ustekinumab and VEdolizumab in inflammatory bowel disease: protocol for an Independent randomised, controlled, multicentre Trial (MOVE-IT).
Authors: Frimor C; Department of Medical Gastrointestinal Diseases, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark Faculty of Health Sciences, Odense, Denmark., Steenholdt C; Department of Medical Gastrointestinal Diseases, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark Faculty of Health Sciences, Odense, Denmark., Widigson ESK; Department of Clinical Pharmacy and Biochemistry, Freie Universität Berlin Institut für Pharmazie, Berlin, Germany.; Graduate Research Training Program PharMetrX (Pharmacometrics and Computational Disease Modelling), Freie Universität Berlin, Berlin, Germany., Kjeldsen J; Department of Medical Gastrointestinal Diseases, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark Faculty of Health Sciences, Odense, Denmark., Larsen L; Department of Gastroenterology and Hepatology, Aalborg Universitetshospital, Aalborg, Denmark.; Center of Molecular Prediction of Inflammatory Bowel Disease (PREDICT), Aalborg Universitet, Copenhagen, Denmark., Burisch J; Gastro Unit Medical Division, Hvidovre Hospital Gastro Unit, Hvidovre, Denmark.; Department of Clinical Medicine, University of Copenhagen Faculty of Health and Medical Sciences, Copenhagen, Denmark., Joergensen MT; Department of Internal Medicine, Vejle Hospital, Vejle, Region Syddanmark, Denmark.; Department of Clinical Medicine, University of Southern Denmark Faculty of Health Sciences, Odense, Denmark., Halling ML; Department of Internal Medicine, Esbjerg Central Hospital, Esbjerg, Denmark., Kloft C; Department of Clinical Pharmacy and Biochemistry, Freie Universität Berlin Institut für Pharmazie, Berlin, Germany., Ainsworth MA; Department of Medical Gastrointestinal Diseases, Odense University Hospital, Odense, Denmark mark.ainsworth@rsyd.dk.; Department of Clinical Research, University of Southern Denmark Faculty of Health Sciences, Odense, Denmark.
Source: BMJ open gastroenterology [BMJ Open Gastroenterol] 2025 Dec 25; Vol. 12 (1). Date of Electronic Publication: 2025 Dec 25.
Publication Type: Journal Article; Clinical Trial Protocol
Journal Info: Publisher: BMJ Publishing Group Ltd & British Society of Gastroenterology Country of Publication: England NLM ID: 101660690 Publication Model: Electronic Cited Medium: Print ISSN: 2054-4774 (Print) Linking ISSN: 20544774 NLM ISO Abbreviation: BMJ Open Gastroenterol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41453773
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: MOdel-informed precision dosing (MIPD) of ustekinumab and VEdolizumab in inflammatory bowel disease: protocol for an Independent randomised, controlled, multicentre Trial (MOVE-IT).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Frimor+C%22">Frimor C</searchLink>; Department of Medical Gastrointestinal Diseases, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark Faculty of Health Sciences, Odense, Denmark.<br /><searchLink fieldCode="AU" term="%22Steenholdt+C%22">Steenholdt C</searchLink>; Department of Medical Gastrointestinal Diseases, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark Faculty of Health Sciences, Odense, Denmark.<br /><searchLink fieldCode="AU" term="%22Widigson+ESK%22">Widigson ESK</searchLink>; Department of Clinical Pharmacy and Biochemistry, Freie Universität Berlin Institut für Pharmazie, Berlin, Germany.; Graduate Research Training Program PharMetrX (Pharmacometrics and Computational Disease Modelling), Freie Universität Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Kjeldsen+J%22">Kjeldsen J</searchLink>; Department of Medical Gastrointestinal Diseases, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark Faculty of Health Sciences, Odense, Denmark.<br /><searchLink fieldCode="AU" term="%22Larsen+L%22">Larsen L</searchLink>; Department of Gastroenterology and Hepatology, Aalborg Universitetshospital, Aalborg, Denmark.; Center of Molecular Prediction of Inflammatory Bowel Disease (PREDICT), Aalborg Universitet, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Burisch+J%22">Burisch J</searchLink>; Gastro Unit Medical Division, Hvidovre Hospital Gastro Unit, Hvidovre, Denmark.; Department of Clinical Medicine, University of Copenhagen Faculty of Health and Medical Sciences, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Joergensen+MT%22">Joergensen MT</searchLink>; Department of Internal Medicine, Vejle Hospital, Vejle, Region Syddanmark, Denmark.; Department of Clinical Medicine, University of Southern Denmark Faculty of Health Sciences, Odense, Denmark.<br /><searchLink fieldCode="AU" term="%22Halling+ML%22">Halling ML</searchLink>; Department of Internal Medicine, Esbjerg Central Hospital, Esbjerg, Denmark.<br /><searchLink fieldCode="AU" term="%22Kloft+C%22">Kloft C</searchLink>; Department of Clinical Pharmacy and Biochemistry, Freie Universität Berlin Institut für Pharmazie, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Ainsworth+MA%22">Ainsworth MA</searchLink>; Department of Medical Gastrointestinal Diseases, Odense University Hospital, Odense, Denmark mark.ainsworth@rsyd.dk.; Department of Clinical Research, University of Southern Denmark Faculty of Health Sciences, Odense, Denmark.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101660690%22">BMJ open gastroenterology</searchLink> [BMJ Open Gastroenterol] 2025 Dec 25; Vol. 12 (1). <i>Date of Electronic Publication: </i>2025 Dec 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial Protocol
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd+%26+British+Society+of+Gastroenterology%22">BMJ Publishing Group Ltd & British Society of Gastroenterology </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101660690 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2054-4774 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220544774%22">20544774 </searchLink><i>NLM ISO Abbreviation: </i>BMJ Open Gastroenterol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41453773
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/bmjgast-2025-001985
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: MOdel-informed precision dosing (MIPD) of ustekinumab and VEdolizumab in inflammatory bowel disease: protocol for an Independent randomised, controlled, multicentre Trial (MOVE-IT).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Frimor C
      – PersonEntity:
          Name:
            NameFull: Steenholdt C
      – PersonEntity:
          Name:
            NameFull: Widigson ESK
      – PersonEntity:
          Name:
            NameFull: Kjeldsen J
      – PersonEntity:
          Name:
            NameFull: Larsen L
      – PersonEntity:
          Name:
            NameFull: Burisch J
      – PersonEntity:
          Name:
            NameFull: Joergensen MT
      – PersonEntity:
          Name:
            NameFull: Halling ML
      – PersonEntity:
          Name:
            NameFull: Kloft C
      – PersonEntity:
          Name:
            NameFull: Ainsworth MA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 12
              Text: 2025 Dec 25
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2054-4774
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMJ open gastroenterology
              Type: main
ResultId 1